Biotechnology: Biological Products (No Diagnostic Substances)

Board MeetingMay 20, 2026, 07:02 AM

Monte Rosa to Participate in Two Investor Conferences

AI Summary

Monte Rosa Therapeutics, a clinical-stage biotechnology company, announced its management will participate in two upcoming investor conferences. The company will present at the TD Cowen 7th Annual Oncology Innovation Summit on May 27, 2026, and the Jefferies Global Healthcare Conference on June 4, 2026. Webcasts of both fireside chats will be available on the company's investor relations website, with archived versions accessible for 30 days.

Key Highlights

Monte Rosa management to participate in TD Cowen 7th Annual Oncology Innovation Summit on May 27, 2026, at 12:00 p.m. ET.
Management will also attend the Jefferies Global Healthcare Conference on June 4, 2026, at 11:40 a.m. ET.
Webcasts of the fireside chats will be available on Monte Rosa's investor relations website.
Archived versions of the webcasts will be accessible for 30 days post-presentation.

View SEC Filing

GLUE

Biotechnology: Biological Products (No Diagnostic Substances)

Monte Rosa Therapeutics, Inc.

Price Impact